BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 8, 2008
View Archived Issues
Acucela Getting $5M Up Front from Otsuka for Vision Drug
Acucela Inc. said it will receive $5 million up front and up to $258 million in milestone payments in a deal with Japan's Otsuka Pharmaceutical Co. Ltd. to co-develop the U.S. biotech's product for vision loss. (BioWorld Today)
Read More
FDA to List Drugs of Concern in Public Quarterly Reports
Read More
Control siRNA May Conflate Specific, Nonspecific Effects
Read More
FDA Reviewers Raise Concerns for Death with Ligand's Fablyn
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Financings Roundup
Read More